ATP acts as a survival signal and prevents the mineralization of aortic valve. (Q54527062)

30 May 2018

title

ATP acts as a survival signal and prevents the mineralization of aortic valve. (English)

1 reference

30 May 2018

author

Sandra Guauque-Olarte

4

1 reference

30 May 2018

Jean-Pierre Després

13

object named as

Jean-Pierre Després

1 reference

30 May 2018

14

Philippe Pibarot

1 reference

30 May 2018

author name string

Nancy Côté

1

1 reference

30 May 2018

Diala El Husseini

2

1 reference

30 May 2018

Andrée Pépin

3

1 reference

30 May 2018

Valérie Ducharme

5

1 reference

30 May 2018

Pascale Bouchard-Cannon

6

1 reference

30 May 2018

Audrey Audet

7

1 reference

30 May 2018

Dominique Fournier

8

1 reference

30 May 2018

Nathalie Gaudreault

9

1 reference

30 May 2018

Habib Derbali

10

1 reference

30 May 2018

Marc D McKee

11

1 reference

30 May 2018

Chantale Simard

12

1 reference

30 May 2018

Yohan Bossé

15

1 reference

30 May 2018

Patrick Mathieu

16

1 reference

30 May 2018

publication date

16 February 2012

1 reference

30 May 2018

Journal of Molecular and Cellular Cardiology

published in

1 reference

30 May 2018

volume

52

1 reference

30 May 2018

issue

5

1 reference

30 May 2018

page(s)

1191-1202

1 reference

30 May 2018

Calcific aortic stenosis: lessons learned from experimental and clinical studies

cites work

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

Calcific aortic stenosis--time to look more closely at the valve

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

Inorganic pyrophosphate: a paracrine regulator of vascular calcification and smooth muscle phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

Haploview: analysis and visualization of LD and haplotype maps

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

A second generation human haplotype map of over 3.1 million SNPs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

Ecto-enzymes: physiology meets pathology

7 January 2021

2 references

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

7 January 2021

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

inferred from DOI database lookup

7 January 2021

based on heuristic

NPP-type ectophosphodiesterases: unity in diversity

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

Nucleotide pyrophosphatases/phosphodiesterases on the move

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

Autotaxin is an exoenzyme possessing 5'-nucleotide phosphodiesterase/ATP pyrophosphatase and ATPase activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

Extracellular nucleotides block bone mineralization in vitro: evidence for dual inhibitory mechanisms involving both P2Y2 receptors and pyrophosphate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

A novel role of extracellular nucleotides in valve calcification: a potential target for atorvastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

Mechanisms of Release of Nucleotides and Integration of Their Action as P2X- and P2Y-Receptor Activating Molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

P2 receptors: intracellular signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

The life of a cell: apoptosis regulation by the PI3K/PKB pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

Inhibition of apoptosis by P2Y2 receptor activation: novel pathways for neuronal survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

Protein kinase B: signalling roles and therapeutic targeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

Bcl-2 family members and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

Insulin resistance and left ventricular hypertrophy in end-stage renal disease: association between the ENPP1 gene and left ventricular concentric remodelling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

Further Evidence For the Role ofENPP1in Obesity: Association With Morbid Obesity in Finns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

Association of the distal region of the ectonucleotide pyrophosphatase/phosphodiesterase 1 gene with type 2 diabetes in an African-American population enriched for nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

Npp1 promotes atherosclerosis in ApoE knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

Up-regulated expression of the phosphodiesterase nucleotide pyrophosphatase family member PC-1 is a marker and pathogenic factor for knee meniscal cartilage matrix calcification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

Uridine adenosine tetraphosphate activation of the purinergic receptor P2Y enhances in vitro vascular calcification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

Regulation of bone resorption and formation by purines and pyrimidines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

Chondrocyte-derived apoptotic bodies and calcification of articular cartilage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YJMCC.2012.02.003

10.1016/J.YJMCC.2012.02.003

7 January 2021

Identifiers

DOI

1 reference

30 May 2018

1 reference

30 May 2018